The rates of HT and DM were significantly higher in ICU patients (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background: We aimed to assess the risk factors for severe COVID-19 and investigate thedifferences between intensive care unit (ICU) and non-ICU patients.Method: The clinical, radiological, and laboratory characteristics of confirmed COVID-19patients between March 15, 2020, and May 30, 2020, were evaluated retrospectively.Results: A total of 157 patients were included in the study.
📊
Key Findings & Data:The median age of the patientswas 47, and 55% were male.
💡
Conclusion & Impact:The rates of HT and DM were significantly higher in ICU patients (p
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters
Abstract
Background: We aimed to assess the risk factors for severe COVID-19 and investigate thedifferences between intensive care unit (ICU) and non-ICU patients.Method: The clinical, radiological, and laboratory characteristics of confirmed COVID-19patients between March 15, 2020, and May 30, 2020, were evaluated retrospectively.Results: A total of 157 patients were included in the study. The median age of the patientswas 47, and 55% were male. Seventeen of them were treated in ICU. All of the patientswho were followed up in ICU were over 50 years old, and 70% were over 65 years old. Themost common comorbid diseases were hypertension (HT) (20%) and diabetes mellitus (DM)(14%). The rates of HT and DM were significantly higher in ICU patients (p
🔖
Cite This Article
GÜNDOĞAN, K., TEMEL, Ş., KETENCİOĞLU, B. B., TATAR, N., TURE, Z., ZARARSIZ, G., ÜNÜVAR, G. K., GÖKAHMETOĞLU, S., TOK, T., AYGEN, B., YILDIZ, O. (2022). Outcomes of COVID-19 Patients Hospitalized in a University Hospital, Turkey. Infectious diseases and clinical microbiology (Online), Cilt: 2 - Sayı: 2, 61–70. https://ajindex.com/articles/539106
1 Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA 2020;10.1001/jama.2020.1097. 2 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5: 536-44. 3 World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. (cited 2020 July 19). Available from: URL: https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/technical-guidance/naming-thecoronavirus- disease-(covid-2019)-and-the-virus-that-causes-it 4 Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382: 1199-207. 5 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]. Lancet 2020; 395: 497-506. 6 Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020; 133: 1025-31. 7 The Republic of Turkey Ministry of Health. COVID-19 Rehberi [COVID-19 Guideline] (cited 2020 May 16). Available from: URL: https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_ Rehberi.pdf 8 Whittle JS, Pavlov I, Sacchetti AD, Atwood C, Rosenberg MS. Respiratory support for adult patients with COVID-19. J Am Coll Emerg Physicians Open 2020; 10.1002/emp2.12071. 9 He Y, Li W, Wang Z, Chen H, Tian L, Liu D. Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China. Infect Control Hosp Epidemiol 2020; 41: 982-3. 10 Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect 2020: 81: e16-e25. 11 Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020 Apr 6; 323:1574-1581. 12 Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience 2020; 42: 5